Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Sunesis Pharmaceuticals (SNSS)

Add to Watchlists
Create an Alert
5.30 -0.06  -1.12% NASDAQ Apr 24, 3:27PM BATS Real time Currency in USD
View Full Chart
SNSS Price Chart
View All Events

SNSS Events

Date Type Description
Mar 06 Misc Sunesis Pharmaceuticals Inc Q4 2013 Earnings Conference Call
Mar 06 Earnings Sunesis Pharmaceuticals Inc Q4 2013 Earnings Results. Estimate: -0.19.
Nov 12 Misc Sunesis to Host Conference Call on November 12th to Discuss Third Quarter Financial Results and Recent Highlights
Nov 12 Earnings Sunesis to Host Conference Call on November 12th to Discuss Third Quarter Financial Results Conference Call. Estimate: -0.19.
Jul 29 Misc Q2 2013 Sunesis Pharmaceuticals, Inc. Earnings Conference Call
Jul 29 Earnings Second Quarter Financial Results. Estimate: -0.20.
May 09 Misc Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights
May 09 Earnings Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights. Estimate: -0.20.
View All Performance Charts

SNSS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sunesis Pharmaceuticals is down 1.85% over the last year vs S&P 500 Total Return up 21.61%, Biogen Idec up 39.24%, and Actelion up 67.22%.

Get Quote for
Advertisement

Portfolio Strategies Featuring SNSS

Did Sunesis Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SNSS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Sunesis Pharmaceuticals, Inc., is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SNSS 5.30 -0.06 -1.12% 288.02M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.